AVENZO THERAPEUTICS

avenzo-therapeutics-logo

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

#SimilarOrganizations #People #Financial #Website #More

AVENZO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Oncology Therapeutics

Founded:
2022-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.avenzotx.com

Total Employee:
1+

Status:
Active

Total Funding:
569.35 M USD

Technology used in webpage:
Euro Cloudflare Hosting Pound Sterling


Similar Organizations

aro-biotherapeutics-logo

Aro Biotherapeutics

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

cello-therapeutics-logo

Cello Therapeutics

Specializes in the development of nanoparticles for cancer treatment.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

nbe-therapeutics-logo

NBE-Therapeutics

NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.

fore-biotherapeutics-logo

Fore Biotherapeutics

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

jakob-dupont_image

Jakob Dupont Board Member @ Avenzo Therapeutics
Board_member

Investors List

deep-track-capital_image

Deep Track Capital

Deep Track Capital investment in Series A - Avenzo Therapeutics

quan-capital_image

Quan Capital

Quan Capital investment in Series A - Avenzo Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Avenzo Therapeutics

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series A - Avenzo Therapeutics

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Series A - Avenzo Therapeutics

ince-capital_image

INCE Capital

INCE Capital investment in Series A - Avenzo Therapeutics

delos-capital_image

Delos Capital

Delos Capital investment in Series A - Avenzo Therapeutics

tf-capital_image

TF Capital

TF Capital investment in Series A - Avenzo Therapeutics

sr-one_image

SR One

SR One investment in Venture Round - Avenzo Therapeutics

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Venture Round - Avenzo Therapeutics

Official Site Inspections

http://www.avenzotx.com Semrush global rank: 5.17 M Semrush visits lastest month: 1.52 K

Unable to get host informations!!!

Loading ...

More informations about "Avenzo Therapeutics"

Avenzo Therapeutics

Keep up with Avenzo on our mission to develop the next generation of oncology therapies for patients.See details»

About Us | Avenzo Therapeutics

Aug 21, 2023 Avenzo Therapeutics is a clinical-stage biotechnology company co-founded in 2022 by Dr. Athena Countouriotis and Dr. Mohammad Hirmand. The company is building and โ€ฆSee details»

Avenzo Therapeutics - Crunchbase Company Profile

Avenzo Therapeutics successfully closed a $150 million oversubscribed Series A-1 financing round to advance its emerging oncology pipeline. The company also received a $150 million investment to pursue a licensing strategy and target โ€ฆSee details»

Avenzo Therapeutics Provides Corporate Update and โ€ฆ

Avenzo Therapeutics, Inc., a clinical-stage biotechnology company developing next-generation oncology therapies for patients, today announced it has entered into an exclusive option agreement with VelaVigo for an exclusive license to โ€ฆSee details»

Avenzo Therapeutics - Overview, News & Similar companies

Avenzo Therapeutics contact info: Phone number: (858) 239-2944 Website: www.avenzotx.com What does Avenzo Therapeutics do? Avenzo Therapeutics is a clinical-stage biotechnology โ€ฆSee details»

Avenzo Therapeutics Company Profile 2024: Valuation, โ€ฆ

Avenzo Therapeutics General Information Description. Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. The company's platform offers a pipeline of oncology drug โ€ฆSee details»

Avenzo Therapeutics - LinkedIn

Exclusive: Avenzo Therapeutics is joining the growing trend of US biotechs in-licensing assets from China-based drug developers as the San Diego startup has inked a deal for VelaVigo's โ€ฆSee details»

Avenzo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Nov 1, 2024 SAN DIEGO--( BUSINESS WIRE )-- Avenzo Therapeutics, Inc . (โ€œAvenzoโ€), a clinical-stage biotechnology company developing the next generation of oncology โ€ฆSee details»

Avenzo Therapeutics - Craft

Avenzo Therapeutics has 5 employees at their 1 location and $150 m in total funding,. See insights on Avenzo Therapeutics including office locations, competitors, revenue, financials, โ€ฆSee details»

Avenzo Therapeutics - Foresite Capital

Avenzo Therapeutics is developing the next generation of oncology therapies for patients. The company was co-founded and led by Athena Countouriotis, MD, and Mohammad Hirmand, โ€ฆSee details»

Avenzo Therapeutics Honored by Goldman Sachs for โ€ฆ

SAN DIEGO, October 16, 2024--Athena Countouriotis, M.D., Co-founder, President and CEO Among Most Exceptional Entrepreneurs at 2024 Goldman Sachs Builders and Innovators SummitSee details»

Avenzo Therapeutics Announces $150 Million Oversubscribed โ€ฆ

Mar 26, 2024 AVZO-021 is being studied in a Phase 1 study in the U.S. for the treatment of advanced solid tumors. Avenzo is headquartered in San Diego, California. For more โ€ฆSee details»

Avenzo Therapeutics Announces Appointment of Garry Nicholson โ€ฆ

SAN DIEGO, October 01, 2024--Avenzo Therapeutics Announces Appointment of Garry Nicholson to Board of Directors as Independent DirectorSee details»

Avenzo Therapeutics Honored by Goldman Sachs for โ€ฆ

Oct 16, 2024 Carla Taub Media Relations [email protected] Sophia Anthony [email protected]. Release Summary. Athena Countouriotis, M.D., Co-founder, โ€ฆSee details»

VelaVigo Announces Exclusive Option Agreement with Avenzo to โ€ฆ

SHANGHAI and BOSTON, Nov. 18, 2024 /CNW/ -- VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and โ€ฆSee details»

Avenzo Adds $150M to Series A Round - San Diego Business Journal

Apr 2, 2024 SAN DIEGO โ€“ Carmel Valley clinical-stage biopharma startup Avenzo Therapeutics has secured an additional $150 million in an oversubscribed Series A round, bringing its total โ€ฆSee details»

Avenzo Therapeutics Honored by Goldman Sachs for โ€ฆ

Oct 16, 2024 For more information, visit us at www.avenzotx.com or on LinkedIn. About Goldman Sachs Goldman Sachs is a leading global financial institution that delivers a broad โ€ฆSee details»

Avenzo Therapeutics Announces Appointment of Garry Nicholson โ€ฆ

AVZO-021 is being studied in a Phase 1 study in the U.S. for the treatment of advanced solid tumors. Avenzo is headquartered in San Diego, California. For more information, visit us at โ€ฆSee details»

Avenzo Therapeutics Staff Directory & Email Format - ContactOut

Explore Avenzo Therapeutics staff directory for direct access to contact details on 8 employees including email format, email address and phone numbers.See details»

Terms of Service | Avenzo Therapeutics

Jan 4, 2024 THIS IS A LEGAL AGREEMENT (โ€œAGREEMENTโ€œ) BETWEEN YOU, THE END USER (ON BEHALF OF YOURSELF, OR YOUR COMPANY OR ORGANIZATION), AND US. โ€ฆSee details»

linkstock.net © 2022. All rights reserved